Patent Assignment
Reel/Frame 025592/0023
Assignment of Assignor's Interest
Recorded: 2011-01-06
Pages: 3
Assignor
SOLTANI, NEPTON
Executed: 2010-12-19
Assignee
WANG, QINGHUA
22 BOND AVENUE, TORONTO, M3B 3R8, CANADA
Covered Properties
(2)
A Method of Ameliorating Symptoms of Type 1-Diabetes Using GABA Related Compounds and GLP-1/Exendin-4 Compounds
Pharmaceutical composition for the treatment of type 1 diabetes
Application:
61/138,957 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 28, 2020
From: WANG, QINGHUA
To: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
Reel/Frame 054759/0655 →
Change of Name
Oct 25, 2022
From: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: GUANGZHOU INNOGEN PHARMCEUTICAL GROUP CO., LTD.
Reel/Frame 061767/0903 →
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 061767 Frame: 0903. Assignor(S) Hereby Confirms the Change of Name.
Jan 4, 2023
From: KUNMING INNOGEN PHARMACEUTICAL TECHNOLOGY CO., LTD.
To: GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO., LTD.
Reel/Frame 062273/0483 →